ClinicalTrials.Veeva

Menu

Role of Oxidized Regenerated Cellulose (ORC) Applied to "Dirty" Surgical Wounds

C

Catholic University of the Sacred Heart

Status and phase

Completed
Phase 4

Conditions

Infections

Treatments

Device: oxidized regenerated cellulose (Fibrillar SURGICEL)
Device: iodoform gauze

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether oxidized regenerated cellulose (ORC) is effective to reduce the risk of surgical site infections (SSI).

Full description

Surgical site infections (SSI) have significant clinical and economic repercussions since they still are the most common cause of nosocomial infections in surgical patients. It is important to bear in mind the growing number of SSI due to antibiotic-resistant microorganisms.

Enrollment

98 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • have an ileostomy or a colostomy
  • are candidates for an elective surgical procedure of ostomy closure

Exclusion criteria

  • immunodeficiency
  • chronic use of corticosteroids or antibiotics
  • chemotherapy and/or radiotherapy in the last 30 days before closure of the stoma
  • concomitant foci of infection

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

98 participants in 2 patient groups

group A-the treatment group
Experimental group
Description:
Group A-patients have their wound, the site of the previous stoma, wad with ORC
Treatment:
Device: oxidized regenerated cellulose (Fibrillar SURGICEL)
group B-the control group
Active Comparator group
Description:
control group-patients have their wound wad with iodoform gauze
Treatment:
Device: iodoform gauze

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems